MDT · Medtronic plc

S&P 500 #111 · NYSE

Risiko 3/10 · Medtech Income & Recovery · $86.88 ▲ 3.16%

Kennzahlen

• Price $86.88
• Market cap $111.2B
• P/E (ttm) 23.29
• Div yield 3.42%
• 52-wk range $73.31 – $106.33
• Index rank #111 / —

Wichtigste Risiken

• Revenue growth lagging peers; market share erosion in cardiac (Growth investors) — MED
• Regulatory/recall risk on device approvals (Revenue stability) — MED
• Currency headwinds (large international revenue) (Reported earnings) — LOW
• 24% below 52-week high; recovery path uncertain (Near-term holders) — LOW

Fazit

World's largest standalone medtech firm (cardiac, neuro, diabetes) offering a compelling 3.6% dividend while navigating a multi-year turnaround.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.